Overall survival in 126 adult patients with BM relapse. (A) All patients. Survival probability after 1 year, 24% ± 4%; after 3 years, 12% ± 3%. (B) According to response and subsequent treatment. CR with subsequent SCT (solid line), 49% ± 8% after 1 year, 36% ± 8% after 3 years (N = 36); CR without SCT (broad dashed line), 33% ± 16% after 1 year, 0% after 3 years (N = 9); and failure/PR (narrow dashed line), 13% ± 4% after 1 year, 4% ± 2% after 3 years. P = .0001.